Security key
09627Y109
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)
CUSIP: 09627Y109
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 65,000,000
- Total 13F shares
- 19,170,288
- Share change
- +441,521
- Total reported value
- $569,347,585
- Put/Call ratio
- 94%
- Price per share
- $29.70
- Number of holders
- 87
- Value change
- +$16,106,841
- Number of buys
- 47
- Number of sells
- 39
Report period
Q3 2016
Institutions
87
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 09627Y109
Recent filing periods:
Top shareholders of BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2016
As of 30 Sep 2016,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,170,288 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, DRIEHAUS CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, Opaleye Management Inc., VANGUARD GROUP INC, Boxer Capital, LLC, and FIL Ltd.
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
82
Q3 2016 holders
87
Holder diff
5
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.